Characterisation of T Cell Receptor Repertoire in Non-small Cell Lung Cancer Patients Treated with Immunotherapy

被引:0
作者
Goni, A. S. [1 ]
Ramirez, A. [2 ]
Cruellas, M. [3 ]
Esteban, P. [2 ]
Galvez, E. M. [4 ]
Gascon-Ruiz, M. [5 ]
Isla, D. [5 ]
Martinez-Lostao, L. [2 ]
Ocariz, M. [5 ]
Pano, J. R. [5 ]
Pardo, J. [2 ]
Quilez, E. [5 ]
Torres-Ramon, I. [5 ]
Yubero, A. [5 ]
Zapata, M. [5 ]
Lastra, R. [5 ]
机构
[1] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
[2] Aragon Hlth Res Inst, Zaragoza, Spain
[3] Hosp Valle De Hebron, Barcelona, Spain
[4] CSIC, Inst Carboquim, Zaragoza, Spain
[5] Hosp Clin Lozano Blesa, Zaragoza, Spain
关键词
LUNG CANCER; BIOMARKER; T-CELL RECEPTOR;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP16.01-03
引用
收藏
页码:S570 / S571
页数:2
相关论文
共 50 条
  • [41] New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer
    Luna, Javier
    Zafra, Juan
    Areses Manrique, Ma Carmen
    Rodriguez, Aurora
    Sotoca, Amalia
    Firvida, Jose Luis
    Chicas-Sett, Rodolfo
    Mielgo, Xabier
    Reyes, Juan Carlos Trujillo
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (11): : 983 - 999
  • [42] Aberrant methylation in non-small cell lung cancer
    Makoto Suzuki
    Ichiro Yoshino
    Surgery Today, 2010, 40 : 602 - 607
  • [43] Emerging Role of Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer
    Mulherkar, Ria
    Grewal, Amardeep S.
    Berman, Abigail T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (04) : 212 - 217
  • [44] Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer
    Duchemann, Boris
    Remon, Jordi
    Naigeon, Marie
    Cassard, Lydie
    Jouniaux, Jean Mehdi
    Boselli, Lisa
    Grivel, Jonathan
    Auclin, Edouard
    Desnoyer, Aude
    Besse, Benjamin
    Chaput, Nathalie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2937 - 2954
  • [45] Early palliative care of non-small cell lung cancer in the context of immunotherapy
    Pieniazek, Malgorzata
    Pawlak, Piotr
    Radecka, Barbara
    ONCOLOGY LETTERS, 2020, 20 (06)
  • [46] Orthotopic Models Using New, Murine Lung Adenocarcinoma Cell Lines Simulate Human Non-Small Cell Lung Cancer Treated with Immunotherapy
    Knott, Eric P.
    Kim, Emily Y.
    Kim, Edison Q.
    Freire, Rochelle
    Medina, Justin A.
    Wang, Yujie
    Chen, Cheng-Bang
    Wu, Chunjing
    Wangpaichitr, Medhi
    Conejo-Garcia, Jose R.
    Lim, Diane C.
    CELLS, 2024, 13 (13)
  • [47] Khorana Score: A Potential New Biomarker for Real Life Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immunotherapy
    Bjornhart, B.
    Hansen, K.
    Jorgensen, T.
    Herrstedt, J.
    Schytte, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S980 - S981
  • [48] The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
    Brahmer, Julie R.
    Govindan, Ramaswamy
    Anders, Robert A.
    Antonia, Scott J.
    Sagorsky, Sarah
    Davies, Marianne J.
    Dubinett, Steven M.
    Ferris, Andrea
    Gandhi, Leena
    Garon, Edward B.
    Hellmann, Matthew D.
    Hirsch, Fred R.
    Malik, Shakuntala
    Neal, Joel W.
    Papadimitrakopoulou, Vassiliki A.
    Rimm, David L.
    Schwartz, Lawrence H.
    Sepesi, Boris
    Yeap, Beow Yong
    Rizvi, Naiyer A.
    Herbst, Roy S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [49] Biomarkers in non-small cell lung cancer prevention
    Hilbe, W
    Dirnhofer, S
    Greil, R
    Wöll, E
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2004, 13 (05) : 425 - 436
  • [50] Aberrant methylation in non-small cell lung cancer
    Suzuki, Makoto
    Yoshino, Ichiro
    SURGERY TODAY, 2010, 40 (07) : 602 - 607